Though these studies have focused on pathologic hypertrophy, the significant elevation of FGF23 over the course of exercise training [32] and pregnancy [75] suggests that FGF23/FGFR4 signaling could play a role in physiologic cardiac hypertrophy as well, which is supported by our study. This evidence concerns the gene FGF23 and cardiac hypertrophy.